Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pathology|June 1, 1994
Bone marrow lymphocyte subsets in myelodysplastic syndromesW Hilbe, W Eisterer, C Schmid, et al.
Leukemia|February 1, 1995
Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemiaC Ludescher, W Eisterer, W Hilbe, et al.
International Journal of Cancer|June 25, 1998
Reversal of multidrug resistance by the staurosporine derivatives CGP 41251 and CGP 42700I Utz, M Spitaler, M Rybczynska, et al.
International Journal of Oncology|December 24, 1998
Monitoring of remission status by fluorescence in situ hybridisation in chronic myeloid leukaemia patients treated with interferon-alphaH C Duba, S Peter, W Hilbe, et al.
Journal of Clinical Pathology|August 31, 2004
CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancerW Hilbe, S Dirnhofer, F Oberwasserlechner, et al.
British Journal of Cancer|October 5, 2013
Quality of life during chemotherapy in lung cancer patients: results across different treatment linesL M Wintner, J M Giesinger, A Zabernigg, et al.
Journal of Clinical Pathology|September 30, 2003
Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosisW Hilbe, S Dirnhofer, F Oberwasserlechner, et al.
Experimental Hematology|February 24, 1999
Detection and quantitation of genetically marked acute myeloid leukemia by competitive polymerase chain reaction after autologous bone marrow transplantation: a preclinical model for minimal residual diseaseT Kühr, O Bechter, S Geley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian womenA M Strasak, K Rapp, W Hilbe, et al.
Leukemia Research|October 31, 2001
CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myelomaW Eisterer, O Bechter, W Hilbe, et al.
Pageof 5